A
Über
Joined AdBio in 2017 with more than 17 years in biotechnology company management. Co-founder of four companies in AdBio portfolio. CEO of Alderaan Biotechnology and Yukin Therapeutics. Previously senior VP at TxCell (acquired by Sangamo), developing cell therapies for chronic inflammatory diseases. 12 years at TxCell managing cell therapy research and regulatory affairs.
Schwerpunkte
biotechnology company management
Region
📍 Ansässig in Paris
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...